We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bone-Disease Markers Monitor Response and Adherence to Osteoporosis Treatments

By LabMedica International staff writers
Posted on 04 May 2009
A range of automated bone-marker tests for the diagnostic and prognostic assessment of patients with or at risk of osteoporosis can be performed on a single serum work area platform. More...
The assays also provide an early indication of response and adherence to treatment.

The Elecsys range of bone marker, hormone, and bone mineral assays allows response to treatment and patient compliance to be monitored at an earlier stage (as early as three to six months after initiation of treatment) and throughout the course of treatment. This encourages adherence to treatment and provides medical staff with valuable information about its effectiveness. The traditional method for measuring response to treatment, bone mass densitometry (BMD), can take up to two years to demonstrate improvement to bone density

The comprehensive range of osteoporosis tests available from Roche Diagnostics (Burgess Hill, UK) for use with cobas or Modular Analytics serum work areas include the Elecsys bone-marker assays (ß-CrossLaps, total PINP [procollagen I N-terminal propertied], N-Mid Osteocalcin and vitamin D3-OH); the Elecsys hormone assays: parathormone, oestradiol, testosterone, dehydroepiandrosterone (DHEA) and sex hormone-binding globulin (SHBG); and bone mineral assays (calcium and phosphate).

According to the U.S. National Osteoporosis Society, one in two women and one in five men over the age of 50 will suffer a bone fracture, the main cause of which is osteoporosis. Among the most commonly used treatments for osteoporosis are the bisphosphonates. Although this group of drugs can be highly effective, gastric side effects and a complex treatment regimen can result in poor adherence. Alternative treatments, such as anabolic therapies, are more expensive, and therefore less likely to be prescribed as a first choice.

Roche is a world-leading healthcare company in the fields of diagnostics and pharmaceutics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis, and treatment of diseases. Roche is a developer of in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology.

Related Links:

Roche Diagnostics



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Gel Cards
DG Gel Cards
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Pathology

view channel
Image: The smart microscope can predict the onset of misfolded protein aggregation, a hallmark of neurodegenerative diseases (Photo courtesy of EPFL)

Self-Driving Microscope Tracks and Analyzes Misfolded Protein Aggregation in Real Time

The accumulation of misfolded proteins in the brain is central to the progression of neurodegenerative diseases like Huntington’s, Alzheimer’s, and Parkinson’s. Yet to the human eye, proteins that are... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.